We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Top Sells

Rank Stock Value
1
MDP
Meredith Corporation
MDP
+$2.9M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.77M
3
CLFD icon
Clearfield
CLFD
+$2.59M
4
QCOM icon
Qualcomm
QCOM
+$2.5M
5
TRTN
Triton International Limited
TRTN
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMBM
51
DELISTED
Cambium Networks
CMBM
$2.67M 0.59%
104,000
– –
BKE icon
52
Buckle
BKE
$2.37B
$2.64M 0.58%
62,400
-15,100
-19% -$684K
NRG icon
53
NRG Energy
NRG
$25.3B
$2.63M 0.58%
61,000
– –
FXB icon
54
Invesco CurrencyShares British Pound Sterling Trust
FXB
$64.6M
$2.6M 0.57%
20,000
– –
KSS icon
55
Kohl's
KSS
$2.13B
$2.57M 0.56%
52,000
-3,800
-7% -$194K
UNM icon
56
Unum
UNM
$14.3B
$2.56M 0.56%
104,000
-51,000
-33% -$1.31M
USNA icon
57
Usana Health Sciences
USNA
$271M
$2.51M 0.55%
24,800
– –
EXPD icon
58
Expeditors International
EXPD
$23.1B
$2.5M 0.55%
18,600
– –
ZUMZ icon
59
Zumiez
ZUMZ
$336M
$2.5M 0.55%
52,000
-10,000
-16% -$457K
VNDA icon
60
Vanda Pharmaceuticals
VNDA
$307M
$2.45M 0.54%
156,000
+32,000
+26% +$558K
IRM icon
61
Iron Mountain
IRM
$36.6B
$2.41M 0.53%
+46,000
New +$2.17M
EBIX
62
DELISTED
Ebix Inc
EBIX
$2.37M 0.52%
78,000
-15,000
-16% -$478K
KR icon
63
Kroger
KR
$35.2B
$2.35M 0.52%
52,000
+41,600
+400% +$1.75M
STX icon
64
Seagate
STX
$195B
$2.35M 0.52%
20,800
-5,200
-20% -$505K
AMGN icon
65
Amgen
AMGN
$218B
$2.34M 0.51%
10,400
+1,100
+12% +$232K
ATKR icon
66
Atkore
ATKR
$3.16B
$2.31M 0.51%
+20,800
New +$2.11M
BIDU icon
67
Baidu
BIDU
$36.9B
$2.31M 0.51%
15,500
– –
SSTK icon
68
Shutterstock
SSTK
$214M
$2.31M 0.51%
20,800
+5,200
+33% +$605K
GILD icon
69
Gilead Sciences
GILD
$162B
$2.27M 0.5%
+31,200
New +$2.15M
VIRT icon
70
Virtu Financial
VIRT
$4.87B
$2.25M 0.49%
78,000
-15,000
-16% -$409K
IMKTA icon
71
Ingles Markets
IMKTA
$1.65B
$2.25M 0.49%
26,000
-10,400
-29% -$793K
VZ icon
72
Verizon
VZ
$194B
$2.16M 0.47%
41,600
+26,100
+168% +$1.36M
VTLE
73
DELISTED
Vital Energy
VTLE
$2.15M 0.47%
35,800
+5,400
+18% +$381K
SIRI icon
74
SiriusXM
SIRI
$10B
$2.15M 0.47%
33,800
-6,500
-16% -$407K
ULTA icon
75
Ulta Beauty
ULTA
$23.2B
$2.14M 0.47%
5,200
– –
1 2
3
4 5

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.